May 2020

Two interactive case studies are featured.

Paul Mathew, MD, DNBPAS, FAAN, FAHS, and Jeffrey Fudin, PharmD, FCCP, FASHP, FFSMB, presented a comprehensive overview of migraine headache, evolving therapies, and the opportunity for pharmacist intervention.

Brought to you by The Sassy Pharmacist.

Palforzia is an oral immunotherapy agent for the mitigation of allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanuts.

The notable federal public health and pharmacy practice law celebrates its 50th anniversary in 2020.

To boost patient participation in these valuable programs, follow a script that emphasizes the benefits.

For best results, address this common, chronic, inflammatory skin condition’s pathogenesis, and consider the possibility of resistance and recurrence.

Patients with this severe condition seem to experience significant differences in quality of life despite having similar visual fields

Haziness around the volume of products and locations of facilities hampers management of shortages, experts say.

Generic products featured in the May 2020 issue.

Take the opportunity to expand career options by becoming certified in a specialized area.

Pharmacy Times™ digital issue (May 2020)

Rx products features in the May 2020 issue.

Four case studies about skin and eye health.

As the nerve exits the eye, the heightened pressure applies mechanical strain to the optic nerve, causing vision loss and potential blindness.

Pharmacists should be prepared for uptick in prescriptions derived from virtual visits.

As more pharmacy technicians join their rolls, organizations gear meeting content toward these key professionals.

Pharmacists should advise patients to moisturize, use topicals, and advance to systemic treatment, if necessary.

Once accredited for use, the new test will improve doctors’ ability to predict and prevent vision loss from glaucoma.

Plainti pharmacist seeks identities of customers in a pharmacy at the time a supervisor allegedly made defamatory statements.

It took the COVID-19 pandemic to accelerate the acceptance and use of remote health care.

Over-the-counter products featured in the May 2020 issue.

The FDA recently advanced proposed regulations to ensure ingredients’ safety and effectiveness.

Pharmacists are in a prime position to convey preventive and treatment options for eyelid inflammation.

With the outbreak of COVID-19, pharmacists throughout the world are called not just to dispense medications but also, importantly, to be a source of critical information and support for the public.

Amid differences in state programs, product labeling improvements must be adopted to protect patients.